Parameters | Unit | Values | Sources |
---|---|---|---|
Physiologic | |||
Vh | l/kg | 0.078 | Davies and Morris, 1993 |
Qh | l/kg | 3.3 | Davies and Morris, 1993 |
Vlumen | l/kg | 0.028a | McConnell et al., 2008 |
AKP-001 | |||
Kp,AKP | 1b | ||
FAKP | 0.01c | ||
M1 | |||
Kp,M1 | 1b | ||
CLr,M1 | l/h/kg | 0.415d | |
FaFgM1 | 1b | ||
M2 | |||
Kp,M2 | 1b | ||
FaFgM2 | H | 0.923e | |
Lag time | 1.5f |
↵a The sum of small intestine and large intestine water content reported by McConnell et al., 2008.
↵b Liver-plasma concentration partition coefficients of AKP-001 and metabolites, and intestinal availability of M1 were assumed to be one.
↵c FAKP was calculated by dividing the dose-normalized AUC of AKP-001 after oral dosing to that after intravenous dosing.
↵d CLr,M1 was estimated by dividing the total amount of M1 excreted in urine by the AUC of M1 after oral administration of AKP-001.
↵e Intestinal availability of M2 was calculated by dividing the hepatic availability by the oral bioavailability (see Materials and Methods).
↵f Lag time for the formation of M2 in gut was considered on the basis of plasma M2 concentration-time profiles after oral administration of AKP-001.